PRL and Alzheimer disease: These common targets are enriched in Alzheimer's disease, serotonergic synapses, HIF-1 signal pathways, estrogen signaling pathways, alcoholism, cocaine addiction, dopaminergic synapses, prolactin signal pathways, gap junctions, and neuroactive ligand-receptor interactions.